Results 251 to 260 of about 274,076 (393)

Severe congenital neutropenia: abnormal growth and differentiation of myeloid progenitors to granulocyte colony-stimulating factor (G-CSF) but normal response to G-CSF plus stem cell factor [PDF]

, 1993
Kjetil Hestdal, K Welte, SO Lie, JR Keller, FW Ruscetti, Abrahamsen Tg   +5 more
openalex   +1 more source

Neoadjuvant Chemotherapy With Chemoradiotherapy for Patients With Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma— Retrospective Review From a Tertiary Care Hospital

Asia-Pacific Journal of Clinical Oncology, EarlyView.
A single‐centre retrospectively analyzed 37 BRPC/LAPC patients receiving neoadjuvant chemotherapy ± chemoradiotherapy. Surgical resection was feasible in 62% of patients, with 38% of patients achieving R0 resections. The median overall survival was 21 months, and disease‐free survival was 12.7 months.
Avtaj Nerwal, Desmond Yip, Sivakumar Gananadha, Amy Shorthouse, Belinda Lee, Ankit Jain   +5 more
wiley   +1 more source

European guidelines on treatment and supportive measures in chronic neutropenias: A consensus between the European Hematology Association and the EuNet-INNOCHRON COST Action based on a systematic evidence review. [PDF]

Hemasphere
Fioredda F, Spanoudakis M, Skokowa J, Tamary H, Farruggia P, Almeida A, Guardo D, Palmblad J, Höglund P, Touw IP, Zeidler C, Warren AJ, Csenar M, Skoetz N, Castagnola E, Ricci E, Dale DC, Newburger PE, Welte K, Papadaki HA, Dufour C.   +20 more
europepmc   +1 more source

In vivo desensitization to leukotriene B4 (LTB4) in the rabbit. Inhibition of LTB4-induced neutropenia during intravenous infusion of LTB4. [PDF]

, 1993
Sylvie Marleau, Christophe Fortin, Patrice E. Poubelle, P Borgeat   +3 more
openalex   +1 more source

Prognosis of Invasive Lobular Carcinoma and Effectiveness of Eribulin in Clinical Practice: A Post Hoc Analysis of a 2‐Year Post‐Marketing Surveillance

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This post hoc analysis of a post‐marketing surveillance evaluated the prognosis of patients with invasive lobular carcinoma (ILC) or invasive ductal carcinoma (IDC) treated with eribulin. Overall survival (OS) from the first‐line chemotherapy was shorter for ILC than IDC cases, but OS from the first date of eribulin administration were similar between ...
Yuko Tanabe, Kenichi Inoue, Masato Takahashi, Hirofumi Mukai, Takashi Yamanaka, Chiyomi Egawa, Yohei Uchida, Yoichi Higashibeppu, Yukinori Sakata, Michiko Sugawara, Junji Tsurutani   +10 more
wiley   +1 more source

Antibodies to myeloid precursor cells in autoimmune neutropenia [PDF]

, 1994
KR Hartman, VF LaRussa, SW Rothwell, TO Atolagbe, FT Ward, Gary L. Klipple   +5 more
openalex   +1 more source

How I diagnose and treat neutropenia

Current opinion in hematology, 2016
D. Dale
semanticscholar   +1 more source

Real‐World Survival Outcomes of Patients With High PD‐L1 Advanced NSCLC Who Received Chemoimmunotherapy Versus Immunotherapy

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Are two drugs better than one in advanced NSCLC? ABSTRACT Background Randomized studies have demonstrated superior overall survival (OS) of pembrolizumab (pembro), both alone and in combination with chemotherapy (chemo) over chemo alone in patients with programmed cell death ligand‐1 (PD‐L1) ≥ 50% advanced non–small cell lung cancer (NSCLC).
Junipearl Cheng, Charlotte McKay, Victoria Bray, Po Yee Yip, Annette Tognela, Peey Sei Kok   +5 more
wiley   +1 more source

8MW0511, a novel, long-acting granulocyte-colony stimulating factor fusion protein for the prevention of chemotherapy-induced neutropenia: final results from the phase III clinical trial. [PDF]

Breast Cancer Res
Wang B, Chen X, Li H, Sun J, Jia X, Sun T, Yao Y, Wang J, Li J, Wang X, Wang X, Geng C, Ren Y, Yang L, Jia J, Chen Y, Li Z, Huang Y, Li B, Ren G, Chen J, Yu S, Mei J, Pei Z, Liu C, Cao X, Deng C, Huang M, Pan Y, Tu Y, Zhang Z, Luo R, Wang P, Dong J, Zhao H, Lu S, Zhu C, Cai S, Wang S, Hu X.   +39 more
europepmc   +1 more source

CONGENITAL T CELL DEFICIENCY WITH NEUTROPENIA AND ERYTHROBLASTOPENIA

, 1985
Claude Perreault, Y Bonny, M Gyger, R Bélanger, DANIELLE ROBITAILLE, J Boileau, MICHELE DAVID, GIOVANNI DʼANGELO, LYSANE BLANCHARD, MARTHE CHARRON   +9 more
openalex   +1 more source